Logo image of SBT

Sterling Bancorp Inc (SBT) Stock Fundamental Analysis

NASDAQ:SBT - Nasdaq - US85917W1027 - Common Stock - Currency: USD

4.84  -0.04 (-0.82%)

After market: 4.88 +0.04 (+0.83%)

Fundamental Rating

1

Taking everything into account, SBT scores 1 out of 10 in our fundamental rating. SBT was compared to 395 industry peers in the Banks industry. The financial health of SBT is average, but there are quite some concerns on its profitability. SBT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SBT had positive earnings in the past year.
SBT had a positive operating cash flow in the past year.
In multiple years SBT reported negative net income over the last 5 years.
In multiple years SBT reported negative operating cash flow during the last 5 years.
SBT Yearly Net Income VS EBIT VS OCF VS FCFSBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

SBT has a worse Return On Assets (0.25%) than 85.86% of its industry peers.
With a Return On Equity value of 1.80%, SBT is not doing good in the industry: 86.35% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 0.25%
ROE 1.8%
ROIC N/A
ROA(3y)-0.06%
ROA(5y)0.06%
ROE(3y)-0.55%
ROE(5y)0.22%
ROIC(3y)N/A
ROIC(5y)N/A
SBT Yearly ROA, ROE, ROICSBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 10.19%, SBT is doing worse than 83.62% of the companies in the same industry.
SBT's Profit Margin has declined in the last couple of years.
SBT does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 10.19%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-46.39%
PM growth 5Y-29.96%
GM growth 3YN/A
GM growth 5YN/A
SBT Yearly Profit, Operating, Gross MarginsSBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

4

2. Health

2.1 Basic Checks

SBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
SBT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SBT has been increased compared to 5 years ago.
There is no outstanding debt for SBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SBT Yearly Shares OutstandingSBT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
SBT Yearly Total Debt VS Total AssetsSBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

There is no outstanding debt for SBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACCN/A
WACC19.84%
SBT Yearly LT Debt VS Equity VS FCFSBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
SBT Yearly Current Assets VS Current LiabilitesSBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for SBT have decreased strongly by -72.24% in the last year.
SBT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -40.76% yearly.
SBT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.07%.
Measured over the past years, SBT shows a very negative growth in Revenue. The Revenue has been decreasing by -15.36% on average per year.
EPS 1Y (TTM)-72.24%
EPS 3Y-55.43%
EPS 5Y-40.76%
EPS Q2Q%-77.29%
Revenue 1Y (TTM)-15.07%
Revenue growth 3Y-15.98%
Revenue growth 5Y-15.36%
Sales Q2Q%-11.28%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y40%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.68%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SBT Yearly Revenue VS EstimatesSBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
SBT Yearly EPS VS EstimatesSBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 -0.5 1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 121.00, SBT can be considered very expensive at the moment.
Based on the Price/Earnings ratio, SBT is valued more expensive than 87.59% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.92. SBT is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 34.23, the valuation of SBT can be described as expensive.
Based on the Price/Forward Earnings ratio, SBT is valued a bit more expensive than the industry average as 79.16% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 21.49. SBT is valued rather expensively when compared to this.
Industry RankSector Rank
PE 121
Fwd PE 34.23
SBT Price Earnings VS Forward Price EarningsSBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

SBT's Price/Free Cash Flow ratio is rather expensive when compared to the industry. SBT is more expensive than 84.86% of the companies in the same industry.
Industry RankSector Rank
P/FCF 201.86
EV/EBITDA N/A
SBT Per share dataSBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SBT does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)3.02
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SBT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Sterling Bancorp Inc

NASDAQ:SBT (3/31/2025, 8:00:02 PM)

After market: 4.88 +0.04 (+0.83%)

4.84

-0.04 (-0.82%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)02-03 2025-02-03/amc
Earnings (Next)05-05 2025-05-05/bmo
Inst Owners26.89%
Inst Owner Change3.18%
Ins Owners2.48%
Ins Owner Change-0.52%
Market Cap253.13M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.63%
Min Revenue beat(2)-6.42%
Max Revenue beat(2)-2.83%
Revenue beat(4)0
Avg Revenue beat(4)-4.92%
Min Revenue beat(4)-7.35%
Max Revenue beat(4)-2.83%
Revenue beat(8)1
Avg Revenue beat(8)-4.4%
Revenue beat(12)2
Avg Revenue beat(12)-4.24%
Revenue beat(16)4
Avg Revenue beat(16)-3.14%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 121
Fwd PE 34.23
P/S 4.27
P/FCF 201.86
P/OCF 171.85
P/B 0.76
P/tB 0.76
EV/EBITDA N/A
EPS(TTM)0.04
EY0.83%
EPS(NY)0.14
Fwd EY2.92%
FCF(TTM)0.02
FCFY0.5%
OCF(TTM)0.03
OCFY0.58%
SpS1.13
BVpS6.4
TBVpS6.37
PEG (NY)3.02
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.25%
ROE 1.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 10.19%
GM N/A
FCFM 2.12%
ROA(3y)-0.06%
ROA(5y)0.06%
ROE(3y)-0.55%
ROE(5y)0.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-46.39%
PM growth 5Y-29.96%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 20.07%
Cap/Sales 0.37%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 20.77%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC19.84%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.24%
EPS 3Y-55.43%
EPS 5Y-40.76%
EPS Q2Q%-77.29%
EPS Next Y40%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.07%
Revenue growth 3Y-15.98%
Revenue growth 5Y-15.36%
Sales Q2Q%-11.28%
Revenue Next Year6.68%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y104.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y104.99%
OCF growth 3YN/A
OCF growth 5YN/A